1 completed, 1 not yet recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
Follow Chronic Subdural Hematoma: new trials by email Literature Review of Chronic Subdural Hematoma trials Research Report on Chronic Subdural Hematoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intra-Arterial Bevacizumab as an Adjunct to Middle Meningeal Artery Embolization for Chronic Subdural Hematoma Bevacizumab (intra-arterial) - Chronic Subdural Hematoma | Phase 1 | Not yet recruiting | Dheeraj Gandhi | 18 | 2027-01-01 | 2026-07-27 |
| Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection Bevacizumab 2 mg/kg, Bevacizumab 4 mg/kg - Chronic Subdural Hematoma | Phase 1 | Completed | The Cooper Health System | 10 | 2024-06-17 | 2026-10-02 |
Hematoma, Subdural, Chronic (2)
Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Chronic Disease (2) · Craniocerebral Trauma (2) · Disease Attributes (2) · Hematoma (2) · Hematoma, Subdural (2) · Hemorrhage (2) · Intracranial Hemorrhage, Traumatic (2) · Intracranial Hemorrhages (2) · Nervous System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Bevacizumab (2) · Infusions, Intra-Arterial (1)
Dheeraj Gandhi (1) · The Cooper Health System (1)
United States (1)
Ajith J Thomas, MD (1) · Jane Khalife, MD (1) · Manisha Koneru, MD (1)